Compass Therapeutics Stock Price History
| CMPX Stock | USD 1.56 0.05 3.31% |
Below is the normalized historical share price chart for Compass Therapeutics extending back to September 16, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Compass Therapeutics stands at 1.56, as last reported on the 28th of November, with the highest price reaching 1.64 and the lowest price hitting 1.53 during the day.
If you're considering investing in Compass Stock, it is important to understand the factors that can impact its price. At this stage we consider Compass Stock to be risky. Compass Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0196, which signifies that the company had a 0.0196% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Compass Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Compass Therapeutics' Mean Deviation of 4.09, risk adjusted performance of 0.0743, and Downside Deviation of 4.69 to double-check if the risk estimate we provide is consistent with the expected return of 0.0947%.
Total Stockholder Equity is likely to rise to about 156 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 11.1 K in 2024. . At this time, Compass Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.40 in 2024, whereas Price Earnings Ratio is likely to drop (4.90) in 2024. Compass Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of April 2021 | 200 Day MA 1.5234 | 50 Day MA 1.7302 | Beta 0.746 |
Compass |
Sharpe Ratio = 0.0196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CMPX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.84 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Compass Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compass Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.5509 | Enterprise Value Ebitda (8.92) | Price Sales 252.5163 | Shares Float 88.6 M | Wall Street Target Price 8 |
Compass Therapeutics Stock Price History Chart
There are several ways to analyze Compass Stock price data. The simplest method is using a basic Compass candlestick price chart, which shows Compass Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 11, 2024 | 1.98 |
| Lowest Price | November 18, 2024 | 1.35 |
Compass Therapeutics November 28, 2024 Stock Price Synopsis
Various analyses of Compass Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Compass Stock. It can be used to describe the percentage change in the price of Compass Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Compass Stock.| Compass Therapeutics Price Daily Balance Of Power | 0.45 | |
| Compass Therapeutics Price Rate Of Daily Change | 1.03 |
Compass Therapeutics November 28, 2024 Stock Price Analysis
Compass Stock Price History Data
The price series of Compass Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 0.79 with a coefficient of variation of 11.27. The prices are distributed with arithmetic mean of 1.68. The median price for the last 90 days is 1.7.| Open | High | Low | Close | Volume | ||
11/28/2024 | 1.54 | 1.64 | 1.53 | 1.56 | ||
| 11/27/2024 | 1.54 | 1.64 | 1.53 | 1.56 | 685,835 | |
| 11/26/2024 | 1.55 | 1.58 | 1.48 | 1.51 | 508,925 | |
| 11/25/2024 | 1.55 | 1.62 | 1.50 | 1.50 | 527,796 | |
| 11/22/2024 | 1.40 | 1.53 | 1.36 | 1.49 | 540,044 | |
| 11/21/2024 | 1.37 | 1.41 | 1.34 | 1.38 | 348,932 | |
| 11/20/2024 | 1.41 | 1.46 | 1.36 | 1.37 | 303,745 | |
| 11/19/2024 | 1.37 | 1.42 | 1.31 | 1.42 | 419,025 | |
| 11/18/2024 | 1.37 | 1.38 | 1.27 | 1.35 | 665,963 | |
| 11/15/2024 | 1.62 | 1.62 | 1.34 | 1.38 | 1,348,934 | |
| 11/14/2024 | 1.72 | 1.75 | 1.58 | 1.59 | 669,087 | |
| 11/13/2024 | 1.83 | 1.85 | 1.67 | 1.69 | 455,750 | |
| 11/12/2024 | 1.90 | 1.94 | 1.77 | 1.79 | 359,426 | |
| 11/11/2024 | 1.87 | 2.00 | 1.81 | 1.90 | 543,504 | |
| 11/08/2024 | 1.87 | 1.87 | 1.79 | 1.80 | 560,996 | |
| 11/07/2024 | 1.85 | 1.91 | 1.74 | 1.84 | 520,037 | |
| 11/06/2024 | 1.85 | 1.90 | 1.81 | 1.83 | 1,238,891 | |
| 11/05/2024 | 1.70 | 1.80 | 1.68 | 1.75 | 313,274 | |
| 11/04/2024 | 1.72 | 1.78 | 1.65 | 1.70 | 413,572 | |
| 11/01/2024 | 1.67 | 1.76 | 1.66 | 1.70 | 359,137 | |
| 10/31/2024 | 1.71 | 1.71 | 1.58 | 1.64 | 516,018 | |
| 10/30/2024 | 1.73 | 1.83 | 1.69 | 1.71 | 377,620 | |
| 10/29/2024 | 1.66 | 1.73 | 1.65 | 1.70 | 400,332 | |
| 10/28/2024 | 1.69 | 1.80 | 1.65 | 1.68 | 283,853 | |
| 10/25/2024 | 1.78 | 1.79 | 1.71 | 1.72 | 269,345 | |
| 10/24/2024 | 1.84 | 1.85 | 1.73 | 1.76 | 321,824 | |
| 10/23/2024 | 1.82 | 1.84 | 1.74 | 1.79 | 302,817 | |
| 10/22/2024 | 1.83 | 1.87 | 1.80 | 1.83 | 746,518 | |
| 10/21/2024 | 1.90 | 1.94 | 1.84 | 1.85 | 264,339 | |
| 10/18/2024 | 1.91 | 1.92 | 1.85 | 1.86 | 198,250 | |
| 10/17/2024 | 1.92 | 1.97 | 1.81 | 1.91 | 2,218,530 | |
| 10/16/2024 | 1.92 | 1.99 | 1.91 | 1.98 | 249,735 | |
| 10/15/2024 | 1.96 | 1.99 | 1.85 | 1.91 | 274,896 | |
| 10/14/2024 | 2.01 | 2.08 | 1.83 | 1.97 | 700,415 | |
| 10/11/2024 | 1.72 | 1.98 | 1.72 | 1.98 | 545,345 | |
| 10/10/2024 | 1.62 | 1.76 | 1.62 | 1.73 | 411,444 | |
| 10/09/2024 | 1.71 | 1.78 | 1.60 | 1.61 | 398,791 | |
| 10/08/2024 | 1.99 | 1.99 | 1.72 | 1.73 | 393,119 | |
| 10/07/2024 | 1.93 | 1.95 | 1.89 | 1.94 | 293,016 | |
| 10/04/2024 | 1.95 | 1.96 | 1.82 | 1.93 | 297,550 | |
| 10/03/2024 | 1.88 | 1.93 | 1.81 | 1.90 | 271,821 | |
| 10/02/2024 | 1.89 | 1.93 | 1.77 | 1.92 | 626,918 | |
| 10/01/2024 | 1.85 | 1.95 | 1.80 | 1.90 | 756,370 | |
| 09/30/2024 | 1.99 | 1.99 | 1.72 | 1.84 | 433,782 | |
| 09/27/2024 | 1.82 | 1.93 | 1.76 | 1.88 | 300,768 | |
| 09/26/2024 | 1.70 | 1.82 | 1.67 | 1.81 | 337,906 | |
| 09/25/2024 | 1.69 | 1.75 | 1.61 | 1.73 | 429,584 | |
| 09/24/2024 | 1.65 | 1.73 | 1.58 | 1.71 | 625,351 | |
| 09/23/2024 | 1.70 | 1.72 | 1.58 | 1.59 | 331,061 | |
| 09/20/2024 | 1.71 | 1.72 | 1.61 | 1.66 | 1,123,660 | |
| 09/19/2024 | 1.71 | 1.79 | 1.70 | 1.73 | 312,367 | |
| 09/18/2024 | 1.75 | 1.75 | 1.63 | 1.63 | 326,435 | |
| 09/17/2024 | 1.75 | 1.78 | 1.62 | 1.66 | 629,483 | |
| 09/16/2024 | 1.75 | 1.86 | 1.61 | 1.71 | 558,778 | |
| 09/13/2024 | 1.59 | 1.65 | 1.52 | 1.65 | 254,163 | |
| 09/12/2024 | 1.50 | 1.56 | 1.50 | 1.54 | 167,000 | |
| 09/11/2024 | 1.57 | 1.58 | 1.50 | 1.50 | 204,236 | |
| 09/10/2024 | 1.64 | 1.65 | 1.52 | 1.58 | 273,687 | |
| 09/09/2024 | 1.42 | 1.64 | 1.42 | 1.59 | 387,470 | |
| 09/06/2024 | 1.50 | 1.50 | 1.43 | 1.43 | 265,583 | |
| 09/05/2024 | 1.54 | 1.61 | 1.48 | 1.49 | 726,306 |
About Compass Therapeutics Stock history
Compass Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Compass is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Compass Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Compass Therapeutics stock prices may prove useful in developing a viable investing in Compass Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 127 M | 78.8 M | |
| Net Loss | -35.3 M | -37.1 M |
Compass Therapeutics Quarterly Net Working Capital |
|
Compass Therapeutics Stock Technical Analysis
Compass Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Compass Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Compass Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Compass Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Compass to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0743 | |||
| Jensen Alpha | 0.0949 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.073 | |||
| Treynor Ratio | 0.1456 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.